Patent · US Active

Method of using a genetically modified mouse that expresses a humanized CTLA-4 gene

US11096383B2 · kind B2 · utility

0Cited by
7References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 30, 2017
Grant dateAug 24, 2021
Priority date—
Expiry dateAug 30, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/11
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to the genetically modified non-human animals that express a human or chimeric CTLA-4, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.